Search research articles
Contact Us
Filters
Showing results (51-60 of 59) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 59 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1989
Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group
F H Valone, M A Friedman, P S Wittlinger, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
June 1, 1991
Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas
F H Valone, D R Gandara, A B Deisseroth, et al.
Journal of Clinical Immunology
|
September 1, 1986
Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid
D G Payan, M Y Wong, T Chernov-Rogan, et al.
Journal of Hematotherapy
|
October 1, 1995
Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu
F H Valone, P A Kaufman, P M Guyre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
F H Valone, P A Kaufman, P M Guyre, et al.
Anesthesiology
|
September 1, 1989
Anaphylactoid reactions to vascular graft material presenting with vasodilation and subsequent disseminated intravascular coagulation
M F Roizen, G M Rodgers, F H Valone, et al.
Journal of Clinical Immunology
|
March 1, 1988
Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen
K B Walker, M H Serwonska, F H Valone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study
P J O'Dwyer, J Manola, F H Valone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer
P A Burch, J K Breen, J C Buckner, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 59) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 59 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1989
Treatment of patients with advanced colorectal carcinomas with fluorouracil alone, high-dose leucovorin plus fluorouracil, or sequential methotrexate, fluorouracil, and leucovorin: a randomized trial of the Northern California Oncology Group
F H Valone, M A Friedman, P S Wittlinger, et al.
Journal of Immunotherapy : Official Journal of the Society for Biological Therapy
|
June 1, 1991
Interleukin-2, cisplatin, and 5-fluorouracil for patients with non-small cell lung and head/neck carcinomas
F H Valone, D R Gandara, A B Deisseroth, et al.
Journal of Clinical Immunology
|
September 1, 1986
Alterations in human leukocyte function induced by ingestion of eicosapentaenoic acid
D G Payan, M Y Wong, T Chernov-Rogan, et al.
Journal of Hematotherapy
|
October 1, 1995
Clinical trials of bispecific antibody MDX-210 in women with advanced breast or ovarian cancer that overexpresses HER-2/neu
F H Valone, P A Kaufman, P M Guyre, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1995
Phase Ia/Ib trial of bispecific antibody MDX-210 in patients with advanced breast or ovarian cancer that overexpresses the proto-oncogene HER-2/neu
F H Valone, P A Kaufman, P M Guyre, et al.
Anesthesiology
|
September 1, 1989
Anaphylactoid reactions to vascular graft material presenting with vasodilation and subsequent disseminated intravascular coagulation
M F Roizen, G M Rodgers, F H Valone, et al.
Journal of Clinical Immunology
|
March 1, 1988
Distinctive patterns of release of neuroendocrine peptides after nasal challenge of allergic subjects with ryegrass antigen
K B Walker, M H Serwonska, F H Valone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 2, 2001
Fluorouracil modulation in colorectal cancer: lack of improvement with N -phosphonoacetyl- l -aspartic acid or oral leucovorin or interferon, but enhanced therapeutic index with weekly 24-hour infusion schedule--an Eastern Cooperative Oncology Group/Cancer and Leukemia Group B Study
P J O'Dwyer, J Manola, F H Valone, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
June 29, 2000
Priming tissue-specific cellular immunity in a phase I trial of autologous dendritic cells for prostate cancer
P A Burch, J K Breen, J C Buckner, et al.
Page
of 6